Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, September 18 - Friday, September 22, 2023), and click each link to read and watch anything you may have missed.
1.) Health risks increase after early ovary removal
In a recent study, increased health risks were seen in women who received premenopausal bilateral oophorectomy when under the age of 46 years.
Click here for the full article.
2.) Premenstrual disorders increase early menopause and vasomotor symptom risks
In a recent study, women with premenstrual disorders were more likely to experience early menopause and vasomotor symptoms.
Click here for the full article.
3.) Ovarian tissue cryopreservation important to offer before gonadotoxic therapy
In a recent study, ovarian tissue cryopreservation was indicated as viable for preventing premature ovarian insufficiency in girls and young women receiving gonadotoxic therapies.
Click here for the full article.
4.) Medical school curricula fail to teach female sexual medicine
In a recent review, a lack of education on female sexual medicine was found across medical institutions.
Click here for the full article.
5.) Sex differences in dermatologic conditions
Data has indicated an increased prevalence of atopic dermatitis among female patients compared to male patients.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More